Search results for the

This policy statement sets out our broad approach to developing memorandums of understanding (MoUs) with other organisations.

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

This annual report contains statistical information, analysis on sector developments, key trends and their causes

This annual report contains statistical information, analysis on sector developments, key trends and their causes

We are encouraging registrants to keep up-to-date with all information and guidance

What we need from providers to maintain their programme's approval through our performance review process.

We recognise that, due to unavoidable circumstances, some registrants may need to defer (put off) their audit.